Cash Flow | Glaxosmithkline Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1238.50-6.5 (-0.52 %)
PREV CLOSE (Rs.) 1245.00
OPEN PRICE (Rs.) 1245.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2246
TODAY'S LOW / HIGH (Rs.)1235.00 1253.95
52 WK LOW / HIGH (Rs.)1230.7 1734.9
NSE1237.85-7.25 (-0.58 %)
PREV CLOSE( Rs. ) 1245.10
OPEN PRICE (Rs.) 1247.10
BID PRICE (QTY) 1237.85 (4)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 23210
TODAY'S LOW / HIGH(Rs.) 1235.00 1254.95
52 WK LOW / HIGH (Rs.)1231 1734

Cash Flow

Select year
ParticularsMar2022Mar2021Mar2020Mar2019Mar2018
Profit Before Tax24756.487230.956472.466539.705221.67
Adjustment-16364.84-256.41131.71-313.63-121.73
Changes In working Capital1198.72457.46440.68-41.931645.58
Cash Flow after changes in Working Capital9590.367432.007044.856184.146745.52
Cash Flow from Operating Activities8107.485779.114905.004094.874727.97
Cash Flow from Investing Activities-4055.084180.26-568.43-1534.53-1041.91
Cash Flow from Financing Activities-5242.42-6955.60-4276.22-3583.59-3066.35
Net Cash Inflow / Outflow-1190.023003.7860.35-1023.25619.71
Opening Cash & Cash Equivalents4051.891048.12987.772011.021391.31
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent2861.874051.891048.12987.772011.02